Genomics Biotechnology & Emerging Medical Technologies Institute e-News Archive

A population health segmentation framework for balancing medical need and COVID-19 risk during and after the pandemic

The pandemic has caused an unequalled healthcare crisis. We are now entering uncharted territory during a “post surge” period, with COVID-19 infection rates waxing and waning, and with a vaccine...

source: Health Affairs

CMS proposes to expand the scope of Medicare coverage determinations

On Sept. 1, the Centers for Medicare & Medicaid Services published a proposed rule that would, for the first time, establish formal criteria to define the “reasonable and necessary” standard for Medicare coverage, and would...

source: JD Supra

FDA approves tramadol oral solution for pain severe enough for opioids

The FDA approved tramadol hydrochloride oral solution 5 mg/1 mL C-IV, an opioid agonist indicated in adults for the management of pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

source: Pain Medicine News

FDA approves Gavreto for treatment of RET-positive, metastatic NSCLC

The FDA granted accelerated approval to pralsetinib for adults with metastatic RET fusion–positive non-small cell lung cancer detected by an FDA-approved test.

source:

An MCO's roadmap to continuous compliance: 3 adjustments to make

As COVID-19 continues to disrupt the economy and keep many out of work, and Medicaid expansion continues across the country, states must prepare for new strains on the Medicaid system.

source: Managed Healthcare Executive

Will AI disrupt the hospital industry?

Artificial intelligence is poised to disrupt the hospital industry, according to a new report from global management consulting firm L.E.K. Consulting. Machine-learning and decision-support systems may soon play more of a role in diagnosis, disease monitoring, treatment...

source: Managed Healthcare Executive

Novel discovery could lead to stem cell-based treatment for heart failure

Blocking an enzyme linked with inflammation makes it possible for stem cells to repair damaged heart tissue, new research from UC Davis Health scientists shows. The enzyme — soluble epoxide hydrolase, or sEH — is a known...

source: News-Medical.Net

Scientists engineer customized blood vessels to support organ regeneration and identification of cancer treatments

A team led by Weill Cornell Medicine scientists has pioneered a method for manufacturing functioning human blood vessels and demonstrated that they can carry blood in lab-grown model organs and tumors. The discovery...

source: Medical Xpress

Artificial Intelligence tools could reduce hospital readmissions

An artificial intelligence method could reduce 30-day hospital readmissions by an estimated 12%, leading to lower annual healthcare costs and improved patient care, according to a study published in PLOS One.

source: HealthITAnalytics

Personalized medicine, genetic testing could shape the future of non-small cell lung cancer

While identifying new genetic targets and developing novel drugs is important for the future of non-small cell lung cancer, more emphasis should be put on improving patient access to existing targeted treatments, according to Dr. Nathan A. Pennell.

source: Cure Today

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed

Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery. The technique,...

source: Johns Hopkins Medicine via ScienceDaily

Significant leap forward in method for cancer treatment

Eindhoven University of Technology Professor Jan C.M. van Hest has announced a breakthrough in non-invasive cancer treatment. His Institute for Complex Molecular Systems partnered with several Chinese research institutions to test a nanotechnology that addresses the drawbacks...

source: Phys.org

New collaboration aims to support health-tech innovations and entrepreneurs

The Health and Technology District in Surrey, B.C. is partnering with Halo Health, Canada's first angel network for healthcare, on a new collaboration to expand and support health-tech innovations and entrepreneurs.

source: News-Medical.Net

Why RNA is a better measure of a patient's current health than DNA

By harnessing the combined power of NGS, machine learning and the dynamic nature of RNA we’re able to accurately measure the dynamic immune response and capture a more comprehensive picture of what’s happening at the site of the solid tumor.

source: MedCityNews

Artificial Intelligence identifies DNA activation code

Scientists have long known that human genes spring into action through instructions delivered by the precise order of our DNA, directed by the four different types of individual links, or “bases,” coded A, C, G and T.

source: Technology Networks

Subscribe to Genomics Biotechnology & Emerging Medical Technologies Institute e-News

*Email:
*First Name:
*Last Name:
*Company:
Title:
Street Address:
City:
State / Province:
Zip / Postal Code:
Country:

Are you a member of NAMCP?	Yes No


Privacy Policy

Browse Categories

Browse by Date

Report: Interoperability does not affect EHR buying decision

A population health segmentation framework for balancing medical need and COVID-19 risk during and after the pandemic

CMS proposes to expand the scope of Medicare coverage determinations

FDA approves tramadol oral solution for pain severe enough for opioids

FDA approves Gavreto for treatment of RET-positive, metastatic NSCLC

An MCO's roadmap to continuous compliance: 3 adjustments to make

Will AI disrupt the hospital industry?

Novel discovery could lead to stem cell-based treatment for heart failure

Scientists engineer customized blood vessels to support organ regeneration and identification of cancer treatments

Artificial Intelligence tools could reduce hospital readmissions

Personalized medicine, genetic testing could shape the future of non-small cell lung cancer

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed

Significant leap forward in method for cancer treatment

New collaboration aims to support health-tech innovations and entrepreneurs

Why RNA is a better measure of a patient's current health than DNA

Artificial Intelligence identifies DNA activation code

RECOMMENDED:

Subscribe to Genomics Biotechnology & Emerging Medical Technologies Institute e-News